CoChat

Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike

Open access
Liu, Lihong, Wang, Pengfei, Nair, Manoj S., Yu, Jian, Rapp, Micah, Wang, Qian, Luo, Yang, Chan, Jasper F-W., Sahi, Vincent, Figueroa, Amir, Guo, Xinzheng V., Cerutti, Gabriele, Bimela, Jude, Gorman, Jason, Zhou, Tongqing, Chen, Zhiwei, Yuen, Kwok-Yung, Kwong, Peter D., Sodroski, Joseph G., Yin, Michael T., Sheng, Zizhang, Huang, Yaoxing, Shapiro, Lawrence, Ho, David D. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)

Preprint — published as 10.1038/s41586-020-2571-7 · Paper page

PreprintCited by 53

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

The SARS-CoV-2 pandemic rages on with devasting consequences on human lives and the global economy 1,2 . The discovery and development of virus-neutralizing monoclonal antibodies could be one approach to treat or prevent infection by this novel coronavirus. Here we report the isolation of 61 SARS-CoV-2-neutralizing monoclonal antibodies from 5 infected patients hospitalized with severe disease. Among these are 19 antibodies that potently neutralized the authentic SARS-CoV-2 in vitro , 9 of which exhibited exquisite potency, with 50% virus-inhibitory concentrations of 0.7 to 9 ng/mL. Epitope mapping showed this collection of 19 antibodies to be about equally divided between those directed to the receptor-binding domain (RBD) and those to the N-terminal domain (NTD), indicating that both of these regions at the top of the viral spike are immunogenic. In addition, two other powerful neutralizing antibodies recognized quaternary epitopes that are overlapping with the domains at the top of the spike. Cryo-electron microscopy reconstructions of one antibody targeting RBD, a second targeting NTD, and a third bridging two separate RBDs revealed recognition of the closed, “all RBD-down” conformation of the spike. Several of these monoclonal antibodies are promising candidates for clinical development as potential therapeutic and/or prophylactic agents against SARS-CoV-2.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2020.06.17.153486

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 41

  1. 10.1038/s41586-020-2012-7 · DOI · Paper page
  2. 10.1016/S0140-6736(20)30185-9 · DOI · Paper page
  3. 10.1016/j.cell.2020.02.058 · doi:10.1016/j.cell.2020.02.058 · Paper page
  4. 10.1126/science.abb2507 · DOI · Paper page
  5. 10.1016/j.cell.2020.02.052 · DOI · Paper page
  6. 10.1016/j.cell.2020.05.025 · DOI · Paper page
  7. 10.1126/science.abc2241 · DOI · Paper page
  8. Hansen, J. et al. High-Throughput Effort Using Both Humanized Mice and Convalescent Humans Yields SARS-CoV-2 Antibody Cocktail. Science, doi: in press (2020).
  9. 10.3389/fimmu.2017.00537 · DOI · Paper page
  10. 10.1371/journal.pmed.0030237 · DOI · Paper page
  11. 10.1080/22221751.2020.1729069 · DOI · Paper page
  12. 10.1126/science.abb7269 · DOI · Paper page
  13. 10.1101/2020.05.11.088674 · DOI
  14. 10.1038/s41423-020-0426-7 · DOI · Paper page
  15. 10.1093/abt/tbaa008 · DOI
  16. 10.1101/2020.05.03.074914 · DOI
  17. 10.1101/2020.05.12.091462 · DOI
  18. 10.1101/2020.05.13.092619 · DOI
  19. 10.1101/2020.05.12.088716 · DOI
  20. 10.1101/2020.05.08.083964 · DOI
  21. 10.1038/s41467-020-16256-y · DOI · Paper page
  22. 10.1101/2020.06.13.150250 · DOI
  23. 10.3389/fimmu.2016.00372 · DOI · Paper page
  24. 10.1093/nar/25.17.3389 · DOI · Paper page
  25. 10.1093/nar/gkn838 · DOI · Paper page
  26. 10.1007/978-1-62703-646-7_6 · DOI · Paper page
  27. 10.1093/bioinformatics/btq461 · DOI · Paper page
  28. 2017, Gene-Specific Substitution Profiles Describe the Types and Frequencies of Amino Acid Changes during Antibody Somatic Hypermutation, Frontiers in immunology, 8, 537, 10.3389/fimmu.2017.00537 · DOI · Paper page
  29. 10.1016/j.jviromet.2010.08.006 · DOI · Paper page
  30. 10.1016/j.jsb.2005.03.010 · DOI · Paper page
  31. 10.1038/nmeth.4169 · DOI · Paper page
  32. 10.1038/s41592-019-0575-8 · DOI · Paper page
  33. 10.1002/jcc.20084 · DOI · Paper page
  34. 10.1038/nmeth.4347 · DOI · Paper page
  35. 10.1002/prot.24551 · DOI · Paper page
  36. 10.1107/S2059798318002425 · DOI · Paper page
  37. 10.1107/S0907444904019158 · DOI · Paper page
  38. 10.1107/S0909049503024130 · DOI · Paper page
  39. 10.1093/nar/gkh398 · DOI · Paper page
  40. 10.1093/cid/ciaa325 · DOI · Paper page
  41. 10.1128/JCM.00310-20 · DOI · Paper page

Cited by

See all 53

Metadata

Authors
Liu, L., Wang, P., Nair, M. S., Yu, J., Rapp, M., Wang, Q., Luo, Y., Chan, J. F.-W., Sahi, V., Figueroa, A., Guo, X. V., Cerutti, G., Bimela, J., Gorman, J., Zhou, T., Chen, Z., Yuen, K.-Y., Kwong, P. D., Sodroski, J. G., Yin, M. T., Sheng, Z., Huang, Y., Shapiro, L., & Ho, D. D.
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2020-06-18
OpenAlex
W3036733096
Cited by
53
References
11
Type
posted content
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike. https://app.cochat.ai/papers/10.1101/2020.06.17.153486
The paper
Liu, L., Wang, P., Nair, M. S., Yu, J., Rapp, M., Wang, Q., Luo, Y., Chan, J. F.-W., Sahi, V., Figueroa, A., Guo, X. V., Cerutti, G., Bimela, J., Gorman, J., Zhou, T., Chen, Z., Yuen, K.-Y., Kwong, P. D., Sodroski, J. G., . . . Ho, D. D. (2020). Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2020.06.17.153486

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.